Login / Signup

Monitoring hepatocellular carcinoma using tumor content in circulating cell-free DNA.

Shifeng LianChenyu LuFugui LiXia YuLimei AiBiao-Hua WuXueyi GongWenjing ZhouXuejun LiangJiyun ZhanYong YuanFang FangZhiwei LiuMingfang JiZongli Zheng
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
The tumor content in ccfDNA is correlated with tumor burden and may help in monitoring HCC one year earlier than clinical diagnosis and in predicting patient prognosis.
Keyphrases
  • case report
  • risk factors